Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ildong Pharmaceutical starts Phase 1 study of new diabetes therapy in Germany

prnasiaJuly 02, 2021

Tag: Ildong , IDG16177 , Diabetes

PharmaSources Customer Service